Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruixiulin versus NovoRapid plus metformin in adults with diabetes
ChiCTR2000031290Phase 3Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Apr 2013
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in diabetes mellitus type 1 (T1D) and type 2 diabetes mellitus (T2DM) comparing Ruixiulin + metformin with NovoRapid + metformin (2 arms). Primary endpoints: Efficacy and safety and Change in HbA1c. Planned start Apr 2013; status: not yet recruiting.
02
Drugs
myl-1601dinsulin aspartmetformin
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2000031290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031290.